Tag Archives: BeiGene

Amgen takes 20% stake in Chinese biotech BeiGene for $2.7 billion

A researcher prepares a sample inside a laboratory at BeiGene Ltd.’s research and development center in Beijing, China, on Thursday, May 24, 2018. Gilles Sabrie | Bloomberg | Getty Images Biotechnology company Amgen announced Thursday it is investing $ 2.7 billion in BeiGene, taking a 20.5% stake in the Chinese biotech firm. The all-cash deal… Read More »

FiercePharmaAsia—AZ’s China business; BeiGene CEO’s $28M pay; Kangmei’s $4.4B accounting error

AstraZeneca warned of slowing China growth after it lost a major government procurement deal for Crestor to a generic drugmaker. BeiGene’s CEO nabbed a $ 15 million special equity award in 2018 and ranked as biopharma’s second-highest-paid exec for the year. China’s Kangmei Pharma saw shares plummet on news that its shares could be delisted after a $ 4.4 billion accounting “error.” 1.… Read More »